Last updated: May 04, 2026

Application No. 18/545,099

Nucleotide Reagent Solutions

Non-Final OA

Filed

Dec 19, 2023

Priority

Oct 16, 2018 — provisional 62/746,542 +2 more

Examiner

HORLICK, KENNETH R

Art Unit

1681

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Life Technologies Corporation

OA Round

1 (Non-Final)

Interview Optional

— +15.1% interview lift. Examiner has a relatively high allowance rate (79%); +15.1% interview lift. A written response may suffice.

Based on 1036 resolved cases, 2023–2026

Examiner Intelligence

HORLICK, KENNETH R View full profile →

Grants 79% — above average

Career Allowance Rate

818 granted / 1036 resolved

+19.0% vs TC avg

Strong +15% interview lift

Without

With

+15.1%

Interview Lift

resolved cases with interview

Typical timeline

2y 5m

Avg Prosecution

25 currently pending

Career history

1061

Total Applications

across all art units

Statute-Specific Performance

§101

5.4%

-34.6% vs TC avg

§103

38.5%

-1.5% vs TC avg

§102

6.4%

-33.6% vs TC avg

§112

15.1%

-24.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1036 resolved cases

Prosecution Timeline

Dec 19, 2023

Application Filed

Mar 12, 2026

Non-Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/154,008

Patent 12612623

Water-Soluble Prolamin, Preparation Thereof, and Uses Thereof for Food-Grade Application Including Prolamin Compositions Combining Prolamin and DNA Taggants

3y 3m to grant Granted Apr 28, 2026

18/460,755

Patent 12612666

SINGLE CELL SEQUENCING

2y 7m to grant Granted Apr 28, 2026

19/088,591

Patent 12606874

SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION

1y 0m to grant Granted Apr 21, 2026

17/831,641

Patent 12584159

SEPARATION OF NUCLEIC ACID COMPONENT COMPOUNDS ON ZWITTERIONIC STATIONARY PHASES

3y 9m to grant Granted Mar 24, 2026

19/091,172

Patent 12577613

SYSTEMS AND METHODS FOR SELECTIVE DNA MULTIPLE DISPLACEMENT AMPLIFICATION OF A DNA MIXTURE;

11m to grant Granted Mar 17, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

79%

Grant Probability

94%

With Interview (+15.1%)

2y 5m (~1m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1036 resolved cases by this examiner. Grant probability derived from career allowance rate.